Search clinical trials for: Merkel Cell Cancer

Total 109078 results

National Cancer Institute (NCI)

Completed

Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas

Pancreatic Cancer | Pancreatic Neoplasm

United States
National Cancer Institute (NCI)

Completed

Effect of Tenofovir DF on Bone Metabolism in Children

HIV Infections

United States
National Cancer Institute (NCI)

Completed

Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer

Breast Cancer | Breast Neoplasms

United States
National Cancer Institute (NCI)

Completed

Markers for Early Detection of Prostate Cancer

Prostate Cancer

United States
National Institute of Allergy and Infectious Diseases...

Completed

Modified Stem Cell Transplantation Procedure for Treating Chronic Granulomatous Disease

Chronic Granulomatous Disease

United States
National Cancer Institute (NCI)

Completed

A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab

Stomach Neoplasms | Breast Neoplasms | Lung Neoplasms | Pancreatic Neoplasms | Colonic Neoplasms

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan Anemia

Diamond Blackfan Anemia

United States
National Institutes of Health Clinical Center (CC)

Completed

Relationship Between Personality and Coping Styles in Bone Marrow Transplant Candidates

Bone Marrow Transplantation | Adaptation, Psychological

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Irinotecan (CPT-11) Administered as a Prolonged Infusion in Adult Patients With Solid Tumors

Neoplasms

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction

Coronary Disease | Arterial Occlusive Diseases | Atherosclerosis | Cytomegalovirus Infections

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effect of Nitric Oxide Donor on Endothelial Progenitor Cells in Patients With Coronary Artery Disease

Coronary Artery Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Study of the Interaction Between the Cells Lining Blood Vessels and Angiotensin-Converting Enzyme

Coronary Disease | Atherosclerosis

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation

Coronary Disease | Atherosclerosis | Vasculitis

United States
National Cancer Institute (NCI)

Completed

A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients

Breast Cancer | Breast Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin

Ovarian Neoplasms

United States
National Cancer Institute (NCI)

Completed

A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas

Gastrointestinal Neoplasms | Pancreatic Neoplasms

United States
National Cancer Institute (NCI)

Completed

Biological Specimen Collection for Laboratory Methods Development and Training Purposes

Healthy

United States
National Cancer Institute (NCI)

Completed

Tenofovir Disoproxil Fumarate to Treat Pediatric HIV

HIV Infection

United States
National Cancer Institute (NCI)

Completed

A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease

Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection

HIV Infections | Acquired Immunodeficiency Syndrome

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of SU101 in Pediatric Patients With Refractory Malignancy

Glioma | Sarcoma

United States
National Cancer Institute (NCI)

Completed

An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections

Mycoses | Candidiasis | Fungemia | Aspergillosis

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections

Atherosclerosis | Pneumonia, Bacterial | Cytomegalovirus Infections | Chlamydia Infections | Postmenopause

United States
National Institutes of Health Clinical Center (CC)

Completed

Nitric Oxide to Improve Blood Flow in Sickle Cell Disease

Sickle Cell Anemia

United States
National Cancer Institute (NCI)

Completed

Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR

Leukoplakia | Periodontal Disease

United States
National Institute of Allergy and Infectious Diseases...

Completed

Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients

HIV Infection

United States
National Cancer Institute (NCI)

Completed

Trial of Pentoxifylline in Patients With Functional Disability Caused by Radiation-Induced Advanced Regional Fibrosis

Fibrosis | Radiation Injuries

United States
National Cancer Institute (NCI)

Completed

Voriconazole to Treat Fungal Infections

Mycoses

United States
National Cancer Institute (NCI)

Completed

Micellar Paclitaxel to Treat Severe Psoriasis

Psoriasis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Treatment of Chronic Granulomatous Disease With Allogeneic Stem Cell Transplantation Versus Standard of Care

Chronic Granulomatous Disease

United States
National Cancer Institute (NCI)

Completed

A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer

Sepsis | Hematologic Diseases | Breast Neoplasms | Neutropenia | Fever

United States
National Institute of Allergy and Infectious Diseases...

Completed

Characteristics of Mast Cells in Mastocytosis

Mastocytosis

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Stem Cell Factor Medication for Aplastic Anemia

Pancytopenia | Aplastic Anemia

United States
National Cancer Institute (NCI)

Completed

A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2

Gastrointestinal Diseases | Candidiasis, Oral | Stomatitis

United States
National Institute of Diabetes and Digestive and...

Completed

A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders

Sickle Cell Anemia | Hemoglobin SC Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Stem Cell Mobilization Potential in Patients With Aplastic Anemia in Remission

Aplastic Anemia

United States
National Cancer Institute (NCI)

Completed

Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial

Neoplasm Metastasis | Breast Neoplasm

United States
National Cancer Institute (NCI)

Completed

Familial Prostate Cancer

Prostatic Neoplasms | Neoplastic Syndromes, Hereditary

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia

Aplastic Anemia

United States
National Cancer Institute (NCI)

Completed

Survey of the Use of Alternative Medical Therapies in Adult Cancer Patients Enrolled in Phase I Clinical Trials

Neoplasm

United States
National Institute of Neurological Disorders and...

Completed

Investigating Endothelial Precursor Cells (EPCs)

Central Nervous System

United States
National Human Genome Research Institute (NHGRI)

Completed

Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency: A Natural History Study

Severe Combined Immunodeficiency

United States
National Cancer Institute (NCI)

Completed

A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer

Colorectal Neoplasms

United States
National Cancer Institute (NCI)

Completed

Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines

HIV Infections | Healthy

United States
National Cancer Institute (NCI)

Completed

Physicians Survey on Genetic Testing

Cancer
National Eye Institute (NEI)

Completed

Modified Intraocular Lens to Reduce Eye Inflammation After Cataract Surgery in Uveitis Patients

Cataracts

United States
National Cancer Institute (NCI)

Completed

Psychosocial Correlates and Coping Strategies Associated With Long-Term Survival of HIV-Infected Children

Depressive Disorder | HIV Infections | Acquired Immunodeficiency Syndrome

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Endothelial Progenitor Cells and Risk Factors for Coronary Artery Disease

Coronary Arteriosclerosis

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients

Ovarian Neoplasms

United States
National Cancer Institute (NCI)

Completed

Determination of HIV-1 Production by the Prostate

HIV Infections

United States

Search clinical trials for: Merkel Cell Cancer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations